News Snapshot:
Pubs baron Bruce Matheison has emerged as one of the biggest investors in collapsed COVID-19 rapid test maker Ellume, owed almost $11 million via various investment entities. Other major creditors in the business, revealed in meeting notes lodged with the Australian Securities and Investments Commission, include specialist hybrid credit fund manager Pure Asset Management (also owed close to $11 million), German biotech Qiagen (owed $15.4 million) and Hong Kong’s Kaifa Technologies (owed $22.3 million). Sean Parsons’s Ellume is in administration, despite its large deal to supply rapid tests in the US. Attila Csaszar In total, the Brisbane-based business, which was...
